RhumbLine Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $408K | Buy |
86,546
+647
| +0.8% | +$3.05K | ﹤0.01% | 2807 |
|
2025
Q1 | $394K | Sell |
85,899
-5,040
| -6% | -$23.1K | ﹤0.01% | 2727 |
|
2024
Q4 | $436K | Buy |
90,939
+827
| +0.9% | +$3.96K | ﹤0.01% | 2758 |
|
2024
Q3 | $423K | Sell |
90,112
-9,442
| -9% | -$44.3K | ﹤0.01% | 2815 |
|
2024
Q2 | $562K | Buy |
99,554
+1,230
| +1% | +$6.95K | ﹤0.01% | 2589 |
|
2024
Q1 | $404K | Sell |
98,324
-1,682
| -2% | -$6.91K | ﹤0.01% | 2796 |
|
2023
Q4 | $422K | Sell |
100,006
-1,935
| -2% | -$8.17K | ﹤0.01% | 2770 |
|
2023
Q3 | $440K | Sell |
101,941
-100,767
| -50% | -$435K | ﹤0.01% | 2684 |
|
2023
Q2 | $1.34M | Buy |
202,708
+9,100
| +5% | +$60K | ﹤0.01% | 2144 |
|
2023
Q1 | $1.32M | Buy |
193,608
+8,485
| +5% | +$57.6K | ﹤0.01% | 2012 |
|
2022
Q4 | $1.37M | Buy |
185,123
+9,481
| +5% | +$70.1K | ﹤0.01% | 1984 |
|
2022
Q3 | $1.74M | Buy |
175,642
+614
| +0.4% | +$6.07K | ﹤0.01% | 1840 |
|
2022
Q2 | $1.91M | Buy |
175,028
+9,611
| +6% | +$105K | ﹤0.01% | 1788 |
|
2022
Q1 | $1.87M | Sell |
165,417
-3,149
| -2% | -$35.6K | ﹤0.01% | 1851 |
|
2021
Q4 | $2.65M | Sell |
168,566
-2,743
| -2% | -$43K | ﹤0.01% | 1733 |
|
2021
Q3 | $2.94M | Sell |
171,309
-20,415
| -11% | -$350K | ﹤0.01% | 1672 |
|
2021
Q2 | $4.12M | Sell |
191,724
-9,147
| -5% | -$197K | 0.01% | 1522 |
|
2021
Q1 | $3.02M | Sell |
200,871
-309
| -0.2% | -$4.64K | ﹤0.01% | 1701 |
|
2020
Q4 | $2.64M | Buy |
201,180
+17,873
| +10% | +$235K | ﹤0.01% | 1707 |
|
2020
Q3 | $1.77M | Sell |
183,307
-15,573
| -8% | -$150K | ﹤0.01% | 1746 |
|
2020
Q2 | $2.28M | Buy |
198,880
+23,350
| +13% | +$267K | ﹤0.01% | 1657 |
|
2020
Q1 | $1.82M | Buy |
175,530
+3,163
| +2% | +$32.8K | ﹤0.01% | 1601 |
|
2019
Q4 | $2.83M | Buy |
172,367
+8,770
| +5% | +$144K | ﹤0.01% | 1596 |
|
2019
Q3 | $2.17M | Buy |
163,597
+4,995
| +3% | +$66.3K | ﹤0.01% | 1697 |
|
2019
Q2 | $2.24M | Buy |
158,602
+8,653
| +6% | +$122K | ﹤0.01% | 1675 |
|
2019
Q1 | $2.76M | Buy |
149,949
+832
| +0.6% | +$15.3K | 0.01% | 1524 |
|
2018
Q4 | $3.9M | Buy |
149,117
+12,196
| +9% | +$319K | 0.01% | 1250 |
|
2018
Q3 | $3.14M | Buy |
136,921
+85,370
| +166% | +$1.96M | 0.01% | 1413 |
|
2018
Q2 | $982K | Buy |
51,551
+9,365
| +22% | +$178K | ﹤0.01% | 2019 |
|
2018
Q1 | $711K | Sell |
42,186
-1,010
| -2% | -$17K | ﹤0.01% | 2082 |
|
2017
Q4 | $657K | Sell |
43,196
-8,125
| -16% | -$124K | ﹤0.01% | 2124 |
|
2017
Q3 | $919K | Buy |
51,321
+600
| +1% | +$10.7K | ﹤0.01% | 2018 |
|
2017
Q2 | $827K | Buy |
50,721
+6,299
| +14% | +$103K | ﹤0.01% | 2043 |
|
2017
Q1 | $622K | Buy |
44,422
+1,550
| +4% | +$21.7K | ﹤0.01% | 2157 |
|
2016
Q4 | $684K | Buy |
42,872
+3,188
| +8% | +$50.9K | ﹤0.01% | 2055 |
|
2016
Q3 | $660K | Sell |
39,684
-4,750
| -11% | -$79K | ﹤0.01% | 2046 |
|
2016
Q2 | $497K | Sell |
44,434
-1,259
| -3% | -$14.1K | ﹤0.01% | 2197 |
|
2016
Q1 | $382K | Buy |
45,693
+1,285
| +3% | +$10.7K | ﹤0.01% | 2392 |
|
2015
Q4 | $413K | Buy |
44,408
+2,515
| +6% | +$23.4K | ﹤0.01% | 2370 |
|
2015
Q3 | $473K | Buy |
41,893
+283
| +0.7% | +$3.2K | ﹤0.01% | 2260 |
|
2015
Q2 | $528K | Buy |
41,610
+2,965
| +8% | +$37.6K | ﹤0.01% | 2289 |
|
2015
Q1 | $359K | Buy |
38,645
+9,625
| +33% | +$89.4K | ﹤0.01% | 2509 |
|
2014
Q4 | $416K | Sell |
29,020
-775
| -3% | -$11.1K | ﹤0.01% | 2387 |
|
2014
Q3 | $309K | Hold |
29,795
| – | – | ﹤0.01% | 2502 |
|
2014
Q2 | $482K | Buy |
29,795
+1,273
| +4% | +$20.6K | ﹤0.01% | 2298 |
|
2014
Q1 | $463K | Sell |
28,522
-1,280
| -4% | -$20.8K | ﹤0.01% | 2276 |
|
2013
Q4 | $370K | Buy |
29,802
+1,810
| +6% | +$22.5K | ﹤0.01% | 2438 |
|
2013
Q3 | $307K | Buy |
27,992
+1,412
| +5% | +$15.5K | ﹤0.01% | 2512 |
|
2013
Q2 | $215K | Buy |
+26,580
| New | +$215K | ﹤0.01% | 2937 |
|